• Biotinylated Human GDF15 on Tris-Bis PAGE under reduced (R) condition and Non reducing (N) condition. The purity is greater than 95%.
  • Immobilized Human GFRAL, hFc Tag at 1 Mu g/ml (100 Mu l/Well) on the plate. Dose response curve for Biotinylated Human GDF15, His Tag with the EC50 of 17. 5ng/ml determined by ELISA.

Human GDF15 protein (Recombinant) (N-His-Avi) {Biotin} (STJP001707)

SKU:
STJP001707

Shipping:
Free Shipping
Current Stock:
Host: HEK293
Note: STRICTLY FOR FURTHER RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Recombinant-Human GDF15-N-His-Avi protein was developed from hek293 and has a target region of N-His-Avi. For use in research applications.
Conjugation: Biotin
Formulation: Lyophilised from 0.2 µm filtered PBS solution pH7.4.
Dilution Range: Upon receipt centrifuge vial to ensure maximal product extraction, recommended: 20sec, 5K RPM
Storage Instruction: The lyophilized protein is stable for at least 1 year from date of receipt at-20°C.
Endotoxin: Endotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than 0.1 ng/µg (1EU/µg).
Gene Symbol: GDF15
Gene ID: 9518
Uniprot ID: GDF15_HUMAN
Immunogen Region: Ala197-Ile308
Immunogen: DNA sequence encoding Human GDF15 including a N-His-Avi tag was expressed in HEK293 Cells. The recombinant protein was then biotinylated site specific using the AVItag biotinylation technology.
Function Hormone produced in response to various stresses to confer information about those stresses to the brain, and trigger an aversive response, characterized by nausea, vomiting, and/or loss of appetite. The aversive response is both required to reduce continuing exposure to those stresses at the time of exposure and to promote avoidance behavior in the future. Acts by binding to its receptor, GFRAL, activating GFRAL-expressing neurons localized in the area postrema and nucleus tractus solitarius of the brainstem. It then triggers the activation of neurons localized within the parabrachial nucleus and central amygdala, which constitutes part of the 'emergency circuit' that shapes responses to stressful conditions. The GDF15-GFRAL signal induces expression of genes involved in metabolism, such as lipid metabolism in adipose tissues. Required for avoidance behavior in response to food allergens: induced downstream of mast cell activation to promote aversion and minimize harmful effects of exposure to noxious substances. In addition to suppress appetite, also promotes weight loss by enhancing energy expenditure in muscle: acts by increasing calcium futile cycling in muscle. Contributes to the effect of metformin, an anti-diabetic drug, on appetite reduction and weight loss: produced in the kidney in response to metformin treatment, thereby activating the GDF15-GFRAL response, leading to reduced appetite and weight. The contribution of GDF15 to weight loss following metformin treatment is however limited and subject to discussion. Produced in response to anticancer drugs, such as camptothecin or cisplatin, promoting nausea, vomiting and contributing to malnutrition. Overproduced in many cancers, promoting anorexia in cancer (cachexia). Responsible for the risk of nausea and vomiting during pregnancy: high levels of GDF15 during pregnancy, mostly originating from the fetus, are associated with increased nausea and vomiting. Maternal sensitivity to nausea is probably determined by pre-pregnancy exposure to GDF15, women with naturally high level of GDF15 being less susceptible to nausea than women with low levels of GDF15 before pregnancy. Promotes metabolic adaptation in response to systemic inflammation caused by bacterial and viral infections in order to promote tissue tolerance and prevent tissue damage. Required for tissue tolerance in response to myocardial infarction by acting as an inhibitor of leukocyte integring activation, thereby protecting against cardiac rupture. Inhibits growth hormone signaling on hepatocytes.
Protein Name Growth/Differentiation Factor 15
Gdf-15
Macrophage Inhibitory Cytokine 1
Mic-1
Nsaid-Activated Gene 1 Protein
Nag-1
Nsaid-Regulated Gene 1 Protein
Nrg-1
Placental Tgf-Beta
Placental Bone Morphogenetic Protein
Prostate Differentiation Factor
Cellular Localisation Secreted
Secreted In The Plasma
Alternative Protein Names Growth/Differentiation Factor 15 protein
Gdf-15 protein
Macrophage Inhibitory Cytokine 1 protein
Mic-1 protein
Nsaid-Activated Gene 1 Protein protein
Nag-1 protein
Nsaid-Regulated Gene 1 Protein protein
Nrg-1 protein
Placental Tgf-Beta protein
Placental Bone Morphogenetic Protein protein
Prostate Differentiation Factor protein
GDF15 protein
MIC1 protein
PDF protein
PLAB protein
PTGFB protein

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance